fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Biocon Ltd

Biocon Ltd

Updated on October 16, 2020

Stock/Share Code - BIOCON

Biocon is engaged in the manufacture of biotechnology products and research services.

Below is the details of BIOCON Biocon Ltd

Market Cap₹45,197 Cr.
Current Price ₹439.6 as on 21 Oct 20
52 Week High / Low Price₹455 / ₹212.2
Face Value₹5
Stock P/E128.35
Book Value₹62.81
Dividend Yield0.13 %
ROCE5.30 %
ROE4.16 %
Sales Growth (3yrs)-8.41 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has reduced debt. Company is virtually debt free. Debtor days have improved from 133.73 to 105.22 days.
Cons: Stock is trading at 5.99 times its book value The company has delivered a poor growth of -2.37% over past five years. Company has a low return on equity of 4.04% for last 3 years. Earnings include an other income of Rs.307.10 Cr. Dividend payout has been low at 12.45% of profits over last 3 years

Biocon Ltd Price Chart

Biocon Ltd Price Chart

Biocon Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹169.4 28.81 ₹124,825.4 Cr. 0.77 -₹1,655.6 Cr. 24.82 -9.42 7585.25 10.53
2. Dr Reddy's Labs ₹5,046.75 36.47 ₹70,902.77 Cr. 0.59 ₹594.6 Cr. -12.11 14.73 4426.50 11.11
3. Cipla ₹767.1 34.95 ₹57,535.92 Cr. 0.42 ₹577.91 Cr. 20.85 8.95 4346.16 11.77
4. Aurobindo Pharma ₹806.2 15.87 ₹47,396.57 Cr. 0.37 ₹780.58 Cr. 20.99 8.82 5924.78 18.73
5. Biocon 128.18 ₹45,138 Cr. 0.13 ₹84.8 Cr. 77.22 8.30 520.70 5.30
6. Torrent Pharma. ₹50.45 39.86 ₹45,039.6 Cr. 0.64 ₹321 Cr. 48.61 1.68 2056.00 15.01
7. Cadila Health. ₹426.35 26.88 ₹38,006.44 Cr. 0.94 ₹454 Cr. 49.54 4.11 3639.90 11.83
8. Alkem Lab ₹2,650.8 23.87 ₹32,553.96 Cr. 0.92 ₹422.01 Cr. 127.54 8.33 2003.49 18.58

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Biocon Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020
Sales -605592648423457443463481524501482521
YOY Sales Growth %-2.09%-8.65%3.48%-26.38%-24.47%-25.11%-28.59%13.72%14.71%13.06%4.24%8.30%
Expenses -532536561373395403420418434424439404
Material Cost %44.95%42.46%43.57%46.00%45.24%42.83%42.68%39.95%41.13%41.19%44.28%42.29%
Employee Cost %15.94%17.62%17.25%15.23%15.81%16.49%17.16%17.10%16.21%17.51%18.64%16.21%
Operating Profit7356885061404263907743117
OPM %12%9%14%12%13%9%9%13%17%15%9%22%
Other Income4637312221006452107661069836
Interest00-0011100000
Depreciation333332222323232424252526
Profit before tax8560872501377971146132158117127
Tax %20%27%17%8%13%8%0%23%20%24%13%33%
Net Profit684472230120737011210612110285
EPS in Rs0.580.370.610.980.510.310.300.950.901.020.860.72
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020TTM
Sales -9121,1631,5611,5561,9382,2022,2422,3022,5882,4191,7861,9882,028
Sales Growth %3.99%27.48%34.22%-0.34%24.57%13.65%1.78%2.69%12.43%-6.52%-26.19%11.35%
Expenses -6968681,0101,2221,5331,7291,8131,8801,9962,1011,5751,7021,701
Material Cost %44.29%47.06%40.98%47.65%46.33%45.08%44.85%42.90%40.00%43.38%44.16%41.63%
Manufacturing Cost %11.39%10.10%9.05%11.00%9.48%10.43%10.76%11.56%10.49%12.33%14.38%15.67%
Employee Cost %9.00%8.57%9.36%12.35%11.80%12.15%12.78%14.07%14.18%16.96%16.36%17.47%
Other Cost %11.63%8.91%5.28%7.55%11.52%10.86%12.50%13.14%12.46%14.17%13.33%10.85%
Operating Profit216295552334405473428422592318210286327
OPM %24%25%35%21%21%21%19%18%23%13%12%14%16%
Other Income-22635767396112927999125422366307
Interest5212111241311
Depreciation74809094951241281401511369298100
Profit before tax114276517304347409428559536306537553534
Tax %2%10%11%16%21%21%16%34%3%22%8%20%
Net Profit112248459256276324361369519238493441414
EPS in Rs0.852.013.752.002.082.562.983.074.331.994.103.673.50
Dividend Payout %54%28%20%39%54%31%28%27%12%25%12%0%

Compounded Sales Growth

  • 10 Years:: 5.51%
  • 5 Years:: -2.37%
  • 3 Years:: -8.41%
  • TTM:: 10.01%

Compounded Profit Growth

  • 10 Years:: 1.96%
  • 5 Years:: -4.23%
  • 3 Years:: -16.13%
  • TTM:: 25.18%

Return on Equity

  • 10 Years:: 20.64%
  • 5 Years:: 38.90%
  • 3 Years:: 30.59%
  • 1 Year:: 59.76%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Share Capital -100100100100100100100100100300300600
Equity Capital100100100100100100100100100300300600
Reserves1,2751,4661,8471,9962,1072,3182,4845,8976,4416,4396,8156,937
Borrowings16419216916113112182370134133714
Other Liabilities -3375064885636756796677327948551,054770
Trade Payables106142200251265268301394450580644521
Advance from Customers28476436813910
Other liability items228356285305404407363332336262401239
Total Liabilities1,8762,2642,6042,8203,0133,2183,3337,0987,4697,7278,2408,311
Fixed Assets -7146786806858519499148949389031,101793
Gross Block9921,0271,1171,2131,4581,7301,8321,9342,1292,2372,5811,994
Accumulated Depreciation2773484385286067819181,0411,1911,3341,4801,200
CWIP3858103825110258172241318254152
Investments3474194866576194931653,8533,8884,1994,0934,953
Other Assets -7771,1091,3351,3961,4921,6742,1962,1792,4022,3072,7922,413
Inventories195245275340359358406505540562802535
Trade receivables296384418445427495555504798740902573
Cash Equivalents67721040179204621643383197356375
Loans n Advances2844072040596876121295264596688
Other asset items-4-4412530467550538406386544136242
Total Assets1,8762,2642,6042,8203,0133,2183,3337,0987,4697,7278,2408,311

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Cash from Operating Activity -116231355162348186125208186355110387
Profit from operations183347571361416489432472647371440492
Receivables-69-98-33-2718-65-65-16-30875-174184
Inventory-27-50-30-66-1815-49-69-35-22-240-145
Payables43175-805760-733140767119962
Loans Advances-8-124-22-106-56-152-14300000
Other WC items0000000-112-74-5121-116
Working capital changes-62-98-165-1433-210-224-58-34072-194-14
Direct taxes-5-19-51-58-71-93-83-205-121-88-137-91
Exceptional CF items000200000000
Cash from Investing Activity --75-120-147-196-8751145-313104-553315-189
Fixed assets purchased-84-77-123-108-243-154-58-220-228-173-258-199
Fixed assets sold022000010307
Investments purchased-1,874-1,942-1,843-1,586-1,600-1,211-1,997-3,435-2,801-839-3,275-4,978
Investments sold2,0101,8751,7631,5111,6251,3182,2163,5252,5013423,3863,200
Interest received344212225276412417
Dividends received221017282825112621143660
Invest in subsidiaries-6-5-12-710-0-000000
Loans to subsidiaries-135-40000-237-198-96-204-215-261
Shares acq cancelled00000000002891,107
Other investing items-101646291027187-100650263328859
Cash from Financing Activity --43-37-100-111-147-187-15873-238-55-208-129
Proceeds from shares00000001019273232
Proceeds from borrowings1840680003040000
Repayment of borrowings0-6-29-19-30-11-37-14-239-1-67-67
Interest paid fin-4-1-1-1-1-1-1-1-4-1-3-1
Dividends paid-50-60-70-90-100-150-100-2110-69-69-60
Financial liabilities00000000000-2
Other financing items-7-10-6-9-16-26-20-15-15-10-101-31
Net Cash Flow-273108-14611450112-3252-25221769

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
ROCE %15%17%27%14%16%17%17%10%8%4%5%5%
Debtor Days1181209810480829080113112184105
Inventory Turnover2.622.802.782.732.973.223.062.512.262.201.381.53

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Biocon Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.